Fluciclovine (18F), also known as anti-1-amino-3-18F-fluorocyclobutane-1-carboxylic acid (anti-3[18F] FACBC), or as Axumin (brand name), is a diagnostic agent indicated for positron emission tomography (PET) imaging in men with suspected prostate cancer recurrence based on elevated prostate specific antigen (PSA) levels.
| Property | Value |
|---|---|
| dbo:abstract |
|
| dbo:alternativeName |
|
| dbo:casNumber |
|
| dbo:chEBI |
|
| dbo:chemicalFormula |
|
| dbo:fdaUniiCode |
|
| dbo:kegg |
|
| dbo:thumbnail | |
| dbo:wikiPageExternalLink | |
| dbo:wikiPageID |
|
| dbo:wikiPageLength |
|
| dbo:wikiPageRevisionID |
|
| dbo:wikiPageWikiLink |
|
| dbp:atcPrefix |
|
| dbp:atcSuffix |
|
| dbp:casNumber |
|
| dbp:chebi |
|
| dbp:chemicalFormula |
|
| dbp:chemspiderid |
|
| dbp:dailymedid |
|
| dbp:drugName |
|
| dbp:iupacName |
|
| dbp:kegg |
|
| dbp:legalEu |
|
| dbp:licenceEu |
|
| dbp:licenceUs |
|
| dbp:molecularWeight |
|
| dbp:tradename |
|
| dbp:unii |
|
| dbp:width |
|
| dbp:wikiPageUsesTemplate | |
| dcterms:subject | |
| rdf:type | |
| rdfs:comment |
|
| rdfs:label |
|
| owl:sameAs | |
| prov:wasDerivedFrom | |
| foaf:depiction | |
| foaf:isPrimaryTopicOf | |
| foaf:name |
|
| is dbo:wikiPageRedirects of | |
| is dbo:wikiPageWikiLink of | |
| is foaf:primaryTopic of |
